Market Opportunity RealView Imaging leads in interactive live holography for medical imaging, with HOLOSCOPE-i already deployed and HOLOSCOPE-x in development. This positions the company to target hospitals and procedure centers seeking advanced visualization tools for interventional cardiology and related minimally invasive fields.

Strategic Partnerships Past and ongoing collaboration with Philips and other healthcare tech ecosystems suggests strong potential to accelerate adoption through strategic alliances, co-development, and bundled solutions with established medical device brands.

Capital Readiness With a $10M Series C completed and revenue in the low millions, RealView demonstrates financial traction and investor backing, making it a viable partner for large-scale pilot programs, co-invested trials, or phased deployment in major medical centers.

Clinical Differentiation The patented Digital Light Shaping technology enabling three-dimensional in-air holograms provides a unique value proposition for guiding complex procedures, offering a compelling differentiator to procurement teams evaluating visualization capabilities.

Global Expansion Likelihood Israel-based startup with international case uses (Toronto valve procedure) and a scalable product roadmap indicates potential for cross-border sales, global clinical reimbursement discussions, and partnerships with multinational hospital networks.